How Often is Each Gene Mutated Within the Cancer Patient Population?

Overview

Journal Mol Cell Oncol

Specialty Oncology

Date 2022 May 9

PMID 35529901

Authors

Gaurav Mendiratta

Michael K Jones

Edward C Stites

Affiliations

Soon will be listed here.

Abstract

Genome sequenced samples from cancer patients helped identify roles of different mutation types and enabled targeted therapy development. However, critical questions like what are the gene mutation rates among the patients? or what genes are most commonly mutated, pan-cancer? have only been recently answered. Here, we highlight this recent advance.

Citing Articles

Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.

Arun A, Liarakos D, Mendiratta G, Kim J, Goshua G, Olson P Pharmacogenomics J. 2025; 25(1-2):5.

PMID: 40044654 DOI: 10.1038/s41397-025-00364-3.

The Abundance of KRAS and RAS Gene Mutations in Cancer.

Stites E Methods Mol Biol. 2024; 2797:13-22.

PMID: 38570449 DOI: 10.1007/978-1-0716-3822-4_2.

References

Mendiratta G, Ke E, Aziz M, Liarakos D, Tong M, Stites E . Cancer gene mutation frequencies for the U.S. population. Nat Commun. 2021; 12(1):5961. PMC: 8514428. DOI: 10.1038/s41467-021-26213-y. View

Merz V, Gaule M, Zecchetto C, Cavaliere A, Casalino S, Pesoni C . Targeting KRAS: The Elephant in the Room of Epithelial Cancers. Front Oncol. 2021; 11:638360. PMC: 7991835. DOI: 10.3389/fonc.2021.638360. View

Cerami E, Gao J, Dogrusoz U, Gross B, Sumer S, Aksoy B . The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5):401-4. PMC: 3956037. DOI: 10.1158/2159-8290.CD-12-0095. View

Sondka Z, Bamford S, Cole C, Ward S, Dunham I, Forbes S . The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat Rev Cancer. 2018; 18(11):696-705. PMC: 6450507. DOI: 10.1038/s41568-018-0060-1. View

. AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017; 7(8):818-831. PMC: 5611790. DOI: 10.1158/2159-8290.CD-17-0151. View